Search results
Results from the WOW.Com Content Network
"Strategic Health Authorities will provide strategic leadership to ensure the delivery of improvements in health and health services locally by PCTs and NHS Trusts within the national framework of developing a patient-centred NHS. They will lead the development and empowerment of innovative and uniformly excellent frontline NHS organisations.
NHS trusts are not trusts in the legal sense but are in effect public sector corporations. Each trust is headed by a board consisting of executive and non-executive directors, and is chaired by a non-executive director. There were about 2,200 non-executives across 470 organisations in the NHS in England in 2015. [2]
An NHS foundation trust is a semi-autonomous organisational unit within the National Health Service in England.They have a degree of independence from the Department of Health and Social Care (and, until the abolition of SHAs in 2013, their local strategic health authority).
The NHS Confederation, formerly the National Association of Health Authorities and Trusts, is a membership body for organisations that commission and provide National Health Service services founded in 1990. The predecessor organisation was called the National Association of Health Authorities in England and Wales.
Some 93% of patients should be seen within two weeks of a GP referral, but trusts are failing to meet this. NHS trusts routinely fail to hit urgent cancer target – data Skip to main content
In 2005 the government announced that the number of strategic health authorities and primary care trusts would be reduced, the latter by about 50 per cent. The result was that, as of 1 October 2006, there were 152 PCTs (reduced from 303) in England, with an average population of just under 330,000 per trust.
Nearly 40% of 18- to 24-year-olds surveyed names New York City as the most overpriced housing market in the country. Despite higher wages, the cost of living in New York, including housing ...
The ARCs are made up of partnerships between universities, NHS providers, local authorities and other organisations. [62] Based at NHS organisations, the NIHR Medtech and In vitro diagnostic Co-operatives (MICs) work with commercial companies on developing new medical technologies and research in vitro diagnostic tests.